Abstract
The phosphatase of regenerating liver (PRL) family, comprising PRL-1, PRL-2 and PRL-3, is a group of prenylated phosphatases that are candidate cancer biomarkers and therapeutic targets. Although several studies have documented that altered expression of PRL-1 or PRL-3 can influence cell proliferation, migration and invasion, there is a dearth of knowledge about the biological functions of PRL-2. Thus, in the current study we have evaluated the role of PRL-2 in cell migration and invasion in human cancer cells. We found that four human lung cancer cells, including A549 cells, overexpress PRL-2 when compared with normal lung cells. PRL-2 knockdown by RNA interference markedly inhibited cell migration and invasion, and this inhibition can be restored by overexpressing the short interference RNA (siRNA)-resistant vector HA-PRL-2m. PRL-2 suppression by siRNA decreased p130Cas and vinculin expression, and decreased extracellular signal-regulated kinase (ERK) phosphorylation, while increasing the phosphorylation of ezrin on tyrosine 146. We found no significant changes in total p53, Akt and c-Src expression levels or their phosphorylation status, suggesting that PRL-2 knockdown could inhibit tumor cell migration and invasion through a Src-independent p130Cas signaling pathway. Ectopic expression of wild-type PRL-2, a catalytic inactive C101S mutant and a C-terminal CAAX deletion revealed a requirement for both the PRL-2 catalytic functionality and prenylation site. Expression of wild-type but not mutant forms of PRL-2 caused ERK phosphorylation and nuclear translocation. These results support a model in which PRL-2 promotes cell migration and invasion through an ERK-dependent signaling pathway.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
Abbreviations
- ERK:
-
extracellular signal-regulated kinase
- FAC:
-
focal adhesion complex
- PRL:
-
phosphatase of regenerating liver
- PTP:
-
protein tyrosine phosphatase
- shRNA:
-
short hairpin RNA
- siRNA:
-
short interference RNA
References
Achiwa H, Lazo JS . (2007). PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells. Cancer Res 67: 643–650.
Basak S, Jacobs SB, Krieg AJ, Pathak N, Zeng Q, Kaldis P et al. (2008). The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation. Mol Cell 30: 303–314.
Cates CA, Michael RL, Stayrook KR, Harvey KA, Burke YD, Randall SK et al. (1996). Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases. Cancer Lett 110: 49–55.
Defilippi P, Di Stefano P, Cabodi S . (2006). p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol 16: 257–263.
Diamond RH, Cressman DE, Laz TM, Abrams CS, Taub R . (1994). PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol Cell Biol 14: 3752–3762.
Fiordalisi JJ, Keller PJ, Cox AD . (2006). PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res 66: 3153–3161.
Forte E, Orsatti L, Talamo F, Barbato G, De Francesco R, Tomei L . (2008). Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3. Biochim Biophys Acta 1783: 334–344.
Guo K, Li J, Tang JP, Koh V, Gan BQ, Zeng Q . (2004). Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels. Cancer Biol Ther 3: 945–951.
Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB, Von Hoff DD . (2002). Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 62: 2890–2896.
Hardy S, Wong NN, Muller WJ, Park M, Tremblay ML . (2010). Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression. Cancer Res 70: 8959–8967.
Kato H, Semba S, Miskad UA, Seo Y, Kasuga M, Yokozaki H . (2004). High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Clin Cancer Res 10: 7318–7328.
Kim W, Kook S, Kim DJ, Teodorof C, Song WK . (2004). The 31-kDa caspase-generated cleavage product of p130cas functions as a transcriptional repressor of E2A in apoptotic cells. J Biol Chem 279: 8333–8342.
Li ZR, Wang Z, Zhu BH, He YL, Peng JS, Cai SR et al. (2007). Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis. Surg Today 37: 646–651.
Liang F, Liang J, Wang WQ, Sun JP, Udho E, Zhang ZY . (2007). PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation. J Biol Chem 282: 5413–5419.
Luo Y, Liang F, Zhang ZY . (2009). PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways. Biochemistry 48: 1838–1846.
Min SH, Kim DM, Heo YS, Kim YI, Kim HM, Kim J et al. (2009). New p53 target, phosphatase of regenerating liver 1 (PRL-1) downregulates p53. Oncogene 28: 545–554.
Ming J, Liu N, Gu Y, Qiu X, Wang EH . (2009). PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer. Pathology 41: 118–126.
Miskad UA, Semba S, Kato H, Yokozaki H . (2004). Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Pathobiology 71: 176–184.
Peng L, Ning J, Meng L, Shou C . (2004). The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer. J Cancer Res Clin Oncol 130: 521–526.
Peng L, Xing X, Li W, Qu L, Meng L, Lian S et al. (2009). PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling. Mol Cancer 8: 110.
Radke I, Gotte M, Kersting C, Mattsson B, Kiesel L, Wulfing P . (2006). Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. Br J Cancer 95: 347–354.
Reddy KB, Nabha SM, Atanaskova N . (2003). Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 22: 395–403.
Stephens BJ, Han H, Gokhale V, Von Hoff DD . (2005). PRL phosphatases as potential molecular targets in cancer. Mol Cancer Ther 4: 1653–1661.
Stephens B, Han H, Hostetter G, Demeure MJ, Von Hoff DD . (2008). Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells. Mol Cancer Ther 7: 202–210.
Wang H, Quah SY, Dong JM, Manser E, Tang JP, Zeng Q . (2007a). PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition. Cancer Res 67: 2922–2926.
Wang J, Kirby CE, Herbst R . (2002a). The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosis. J Biol Chem 277: 46659–46668.
Wang L, Peng L, Dong B, Kong L, Meng L, Yan L et al. (2006). Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome. Ann Oncol 17: 1517–1522.
Wang Q, Holmes DI, Powell SM, Lu QL, Waxman J . (2002b). Analysis of stromal-epithelial interactions in prostate cancer identifies PTPCAAX2 as a potential oncogene. Cancer Lett 175: 63–69.
Wang Y, Li ZF, He J, Li YL, Zhu GB, Zhang LH . (2007b). Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis. Int J Colorectal Dis 22: 1179–1184.
Wu X, Zeng H, Zhang X, Zhao Y, Sha H, Ge X et al. (2004). Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am J Pathol 164: 2039–2054.
Yagi T, Morimoto A, Eguchi M, Hibi S, Sako M, Ishii E et al. (2003). Identification of a gene expression signature associated with pediatric AML prognosis. Blood 102: 1849–1856.
Zamir E, Geiger B . (2001). Molecular complexity and dynamics of cell-matrix adhesions. J Cell Sci 114: 3583–3590.
Zeng Q, Dong JM, Guo K, Li J, Tan HX, Koh V et al. (2003). PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res 63: 2716–2722.
Zeng Q, Si X, Horstmann H, Xu Y, Hong W, Pallen CJ . (2000). Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome. J Biol Chem 275: 21444–21452.
Acknowledgements
This work was supported by a grant from the National Institutes of Health National Cancer Institute (CA78039) and the Fiske Drug Discovery Fund.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Wang, Y., Lazo, J. Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion. Oncogene 31, 818–827 (2012). https://doi.org/10.1038/onc.2011.281
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.281
Keywords
This article is cited by
-
Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases
Stem Cell Research & Therapy (2023)
-
A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3)
Scientific Reports (2021)
-
The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesis
Oncogene (2015)
-
PRL-3 Promotes the Malignant Progression of Melanoma via Triggering Dephosphorylation and Cytoplasmic Localization of NHERF1
Journal of Investigative Dermatology (2015)
-
Protein tyrosine phosphatases as potential therapeutic targets
Acta Pharmacologica Sinica (2014)